Breaking News
Get 40% Off 0
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did. Read how
Close

PYC Therapeutics Ltd (PYC)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.100 +0.004    +4.17%
10/05 - Closed. Currency in AUD ( Disclaimer )
Type:  Equity
Market:  Australia
ISIN:  AU000000PYC7 
  • Volume: 661,637
  • Bid/Ask: 0.098 / 0.105
  • Day's Range: 0.098 - 0.105
PYC Therapeutics Ltd 0.100 +0.004 +4.17%

PYC Therapeutics Ltd Company Profile

 
Get an in-depth profile of PYC Therapeutics Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

5

Equity Type

ORD

PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of drug solutions in the areas of RNA therapeutics in Australia. The company’s preclinical development programs include VP-001, a drug program for retinitis pigmentosa type 11; PYC-001, a drug program for the treatment of autosomal dominant optic atrophy; and PYC-002 a drug program for the treatment of a severe neurodevelopmental disorder. It also focuses on the development of programs for kidney, neurodevelopmental, retinal, and central nervous system diseases. PYC Therapeutics Limited has academic-industry collaborations with Murdoch University to support drug discovery and development efforts in the field of neurodegenerative disorders. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia.

Contact Information

Address Harry Perkins Institute of Medical Research 6 Verdun Street
Nedlands, 6009
Australia
Phone 61 8 6151 0992
Fax 61 8 9315 5475
Web pyctx.com

Top Executives

Name Age Since Title
Judy Lieberman - 2017 Member of Scientific Advisory Board
Shohei Koide - 2018 Member of Scientific Advisory Board
David G. Birch - 2021 Member of Ophthalmology Clinical Advisory Board
Mark Pennesi - 2021 Member of Ophthalmology Clinical Advisory Board
Stephen K. Doberstein 64 2017 Member of Scientific Advisory Board
Alan William Tribe 74 2018 Non-Executive Chair of the Board
Michael Rosenblatt 75 2021 Independent Non-Executive Director
Jason Haddock 53 2021 Independent Director
Jacque Duncan - 2021 Member of Ophthalmology Clinical Advisory Board
Rohan Hockings 40 2016 CEO & Executive Director
Rakesh Veedu - 2019 Member of Scientific Advisory Board
Fred K. Chen - 2019 Member of Scientific Advisory Board & Member of Ophthalmology Clinical Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PYC Comments

Write your thoughts about PYC Therapeutics Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email